High Lipoprotein(a) Levels’ Hit on Heart Health Doesn’t Discriminate
Atherogenic particle appeared to be a risk factor regardless of age, sex, race, diabetes status
Atherogenic particle appeared to be a risk factor regardless of age, sex, race, diabetes status
AbstractBackgroundIncomplete treatment of congestion often leads to worsening heart failure (HF). The remote dielectric sensing (ReDS) system is an electromagnetic energy–based technology that accu…
SERVIR is a NASA and USAID partnership that supports locally led efforts to strengthen climate resilience, food and water security, forest and carbon management, and…
AbstractBackgroundAnthracycline-induced cardiotoxicity (AIC) debilitates quality of life in cancer survivors. Serial characterizations are lacking of the molecular processes occurring with AIC.Obje…
A roundtable discussion, moderated by Thomas Martin, MD, of the UCSF Helen Diller Family Comprehensive Cancer Center, focused on CAR T-cell therapy considerations in the…
My esteemed guest on this Healthcare unfiltered podcast is Dr. Manmeet Ahluwalia, Deputy Director, Chief Scientific Officer, and Chief of Solid Tumor Medical…
AbstractBackgroundQuantification of myocardial changes in severe aortic stenosis (AS) is prognostically important. The potential for comprehensive myocardial assessment pre–transcatheter aortic val…
Hosted by Chadi Nabhan, MD, the inaugural HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 3-4 in Chicago.
Abstract. Bispecific antibodies, a novel immunotherapy with promising efficacy against multiple myeloma, form immune synapses between T-cell surface marker CD3
Introduction Multiple myeloma (MM) is a malignancy of bone marrow plasma cells, characterized by monoclonal immunoglobulins in the blood or urine and assoc
Blood Cancer Journal – Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response